share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Romanelli Joseph

SEC announcement ·  Feb 14 18:02
Summary by Moomoo AI
Joseph Romanelli, President of Human Health International at Merck & Co., Inc., completed a sale of 1,000 shares of the company's common stock on February 13, 2024. The transaction was carried out on the open market with the shares sold at a price of $124.89 each, totaling approximately $124,888 in value. Following the sale, Romanelli's direct holdings in Merck & Co. amount to 19,569.325 shares. The sale reflects a transaction in the normal course of trading and is part of the regular financial activities of corporate executives.
Joseph Romanelli, President of Human Health International at Merck & Co., Inc., completed a sale of 1,000 shares of the company's common stock on February 13, 2024. The transaction was carried out on the open market with the shares sold at a price of $124.89 each, totaling approximately $124,888 in value. Following the sale, Romanelli's direct holdings in Merck & Co. amount to 19,569.325 shares. The sale reflects a transaction in the normal course of trading and is part of the regular financial activities of corporate executives.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more